MarketingRx roundup: Eli Lilly debuts unbranded ‘memory’ issues TV ad; Big Pharmas amp social media spending
As Eli Lilly readies for the FDA review of Alzheimer’s disease candidate donanemab next month, it’s rolling out an unbranded, 15-second TV commercial about memory …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.